16.12.2012 Views

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

24/06/2005 - Controller General of Patents, Designs, and Trade Marks

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(21) Application No.: 602/MUMNP/2004<br />

PCT/FR01/00861<br />

A (22) Date <strong>of</strong> filing <strong>of</strong> Application: 27/10/2004<br />

(54)<br />

Title <strong>of</strong> the invention: N-(HETEROCYCLYL) BENZENE- OR -PYRIDINE<br />

SULPHONAMIDES AS ANTITHROMBOTIC AND ANTICOAGULANT AGENTS<br />

(51) International classification: C07D 401/14 (71) Name <strong>of</strong> the Applicant:<br />

(30) Priority Data:<br />

(31) Document No: 00/03, 7<strong>24</strong><br />

(32) Date: 23.03.2000<br />

(33) Name <strong>of</strong> convention country: FR<br />

(66) Filed U/s. 5(2): NO. (72)<br />

(61) Patent <strong>of</strong> addition to application No.: NIL<br />

(62) Filed on: N.A.<br />

(63) Divisional to Application No.:<br />

IN/PCT/2002,01213/MUM<br />

(64) Filed on: 05/09/2002<br />

SANOFI-SYNTHELABO<br />

Address <strong>of</strong> the Applicant:,<br />

174, AVENUE DE FRANCE,<br />

75013 PARIS<br />

Name <strong>of</strong> the Inventors:<br />

1) JEAN- MICHEL ALTENBURGER<br />

2) CREMER<br />

3) LASSALLE<br />

4) MATROUGUI<br />

(57) Abstract: The invention concerns compounds <strong>of</strong> formula (I) wherein W can represent a-<br />

(CH2)2-,-(CH2)-C=C or –CH2-CH=CH- group; R2 can in particular represent a piperidinyl group,<br />

a 1,2,3,6-tetrahydropyridinyl group optionally substituted, a hexahydro-1 (H)-azepinyil<br />

group, a piperazinyl group optionally substituted or a morphinopolinyl group; R3 can represent<br />

a-COR1 group; A can in particular represent a phenyl group optionally substituted, a heterocycle<br />

or a cyclopentyl group <strong>and</strong> B can in particular represent a pyridyl group, an aminopyrazinyl<br />

group, anaminopyridazinyl group, a pyrimidinyl group optionally substituted by an amino<br />

group, a piperidinyl group or an aminopyridinyl group optionally substiotuted on the pyridine by<br />

a (C1-C4) alkyl or (C1-C4) alkoxy group, the amino group capable<strong>of</strong> being optionally substituted<br />

by a (C1-C4) alkyl group. The invention also concerns the preparation <strong>of</strong> said compounds <strong>and</strong><br />

their therapeutic use.<br />

Figure: 1<br />

The Patent Office Journal <strong>24</strong>.<strong>06</strong>.<strong>2005</strong> 17996

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!